1. Introduction {#sec0001}
===============

Parkinson\'s disease (PD) is the second most common neurodegenerative disorder characterized by the clinical tetrad of motor dysfunction, including resting tremor, rigidity, akinesia (bradykinesia) and postural instability ([@bib0016]). Besides predominant motor symptoms, a wide range of non-motor symptoms (NMS) is highly prevalent in PD patients. Depression is one of the most common NMS, occurring in around 35% of patients ([@bib0027]). Although depression is also a common symptom of other illnesses and often occurs in elderly population without PD, it\'s suggested by some evidence that depression is more frequent in PD patients than in general persons with the same age or patients with other chronic and disabling diseases, such as diabetes ([@bib0024]). Along with the progression of PD, depression has been associated with reduced functioning, cognitive impairment and increased stress, which greatly contribute to the poor quality of life for PD patients ([@bib0037]). Despite of its great impact, the neural basis of depression in PD is still not well understood and research is underway to investigate brain abnormalities underlying depressive symptoms as well as to assist clinical diagnosis on the basis of identified markers.

Modern imaging methods, including PET and MRI, have provided useful tools to explore brain differences between PD patients with and without depression. Within the last few years, neuroimaging reports have provided evidence that depression was the result of regional abnormalities in the prefrontal cortex, the basal ganglia and the limbic system (including the thalamus, ventral striatum, amygdala, insula and cingulate cortex), which were modulated by the neurotransmitter systems of dopaminergic, serotoninergic, cholinergic and noradrenergic ([@bib0028]; [@bib0009]; [@bib0002]). Specifically in a PET study investigating depression in PD, the decrease of serotonin 1A receptor availability was exhibited in the right insula, left hippocampus, left superior temporal cortex and orbitofrontal cortex of patients with depression, compared to those without depression ([@bib0002]). Moreover, increased gray matter volume in bilateral mediodorsal thalamic nuclei was found in depressed PD patients by voxel-based morphometry ([@bib0008]).

In addition to the regional abnormalities, depression in PD was also related to network differences ([@bib0030]; [@bib0020]; [@bib0019]; [@bib0013]). Resting-state functional MRI (rs-fMRI) can characterize spontaneous brain activity and identify brain networks with co-varied patterns, which make it a powerful technique to examine network abnormalities associated with depression in PD patients without performing any specific task. In a rs-fMRI study analyzing the amplitude of low-frequency fluctuations and functional connectivity (FC) in the whole brain, depressed PD patients were characterized by increased regional spontaneous neural activity in the orbitofrontal area and decreased functional integration within the prefrontal-limbic network, compared to non-depressed patients and healthy controls ([@bib0020]). [@bib0019] showed that depressed PD patients had decreased FC in the left dorsolateral prefrontal cortex and right superior temporal gyrus, and increased FC in the right posterior cingulate cortex (PCC), in comparison to non-depressed patients. In addition, the FC in the PCC was negatively correlated with depression scores. However, these regional and network abnormalities were found in PD patients from a small cohort. With sufficient number of patients, classifiers can be constructed to distinguish between depressed and non-depressed patients, which potentially help depression diagnosis in PD patients.

In this study, we collected rs-fMRI data from advanced PD patients (PD duration \> 5 years) and healthy control subjects in our cohort. To investigate the relationship between the whole-brain functional connectivity and depression, we extracted FC features based on the patient-specific intrinsic connectivity networks, and identified all the features with significant discriminative power for depression diagnosis under the combination of random forest model and cross validation, which might advance our understanding for the neural substrates of depression in PD.

2. Materials and methods {#sec0002}
========================

2.1. Participants and clinical assessment {#sec0003}
-----------------------------------------

According to the UK Parkinson\'s Disease Brain Bank criteria ([@bib0014]), advanced idiopathic PD patients (PD duration \> 5 years) were consecutively recruited from the Department of Functional Neurosurgery, Shenzhen Second People\'s Hospital between March 2014 and October 2018. Participants were excluded if they were: (a) having cerebrovascular disorders, including a history of head injury, a previous stroke, a history of seizure, intracranial mass, hydrocephalus, previous neurological surgery and other neurological diseases; (b) having psychiatric diseases other than depression; (c) treated with antidepressants or other psychiatric therapy; (d) having excessive head movement (mean absolute displacement \> 3.5 mm) during MRI scanning. After screening, a total of 156 PD patients were enrolled into the study. 59 of them were diagnosed to have depression according to the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) criteria ([@bib0035]) by an experienced psychiatrist. 45 healthy, age- and sex-matched participants who did not have any neurological or psychiatric disorders were included as healthy controls. This study was approved by the local ethics committee of our hospital for human research. All participants were fully informed about the purpose and procedures of the study, and provided written informed consent before enrollment.

The motor and non-motor symptoms of patients were assessed by an experienced clinical neurologist using multiple rating scales when medication off, including the Unified Parkinson\'s Disease Rating Scale part III (UPDRS-III), the 24-item Hamilton Depression Rating Scale (HDRS), the Beck Depression Inventory (BDI), the Montreal Cognitive Assessment Scale (MoCA), the Mini-Mental State Examination (MMSE) and the Pittsburgh Sleep Quality Index (PSQI).

2.2. MRI dataset acquisition and preprocessing {#sec0004}
----------------------------------------------

Scanning was performed on a 3T MRI system (Prisma, Siemens, Erlangen, Germany) using a 32-channel head coil. Patients were scanned more than 12 h after the withdrawal of their dopaminergic medications in a clinically defined "off-state". The protocol included high-resolution T1-weighted MR images and rs-fMRI images (EPI, resolution 3 × 3 × 3.5 mm^3^, TE/TR = 28 ms/2000 ms, 240 vol in 8 min, eyes closed).

The preprocessing of rs-fMRI data as performed in FSL ([@bib0017]), included brain extraction, slice timing correction, rigid-body motion correction, spatial smoothing using a Gaussian kernel of FWHM of 6 mm, and high-pass temporal filtering of 150 s. 24 motion parameters of each participant, derived from the six rigid-body parameter time series, were extracted for subsequent motion artifact removal. They consisted of the six rigid-body parameter time series, the backward-looking temporal derivatives, and the squares of the twelve resulting regressors. Using the MELODIC tool in FSL, Single-subject probabilistic independent component analysis (ICA) was performed with automated dimensionality estimation for ICA-based artifact removal ([@bib0004]).

To remove the effects of motion, non-neural physiology, scanner artifacts and other confounds, we used the tool of FMRIB\'s ICA-based Xnoiserfier -- FIX ([@bib0012]; [@bib0029]) for noise cleaning. The FIX employed machine learning approaches to classify the single-subject ICA results of rs-fMRI data into 'good' and 'bad' components, respectively. First, the FIX was trained on the randomly chosen sample of 50 participants in our cohort by an experienced imaging expert, which obtained an accuracy of 95.6% true-positive ratio and 88.1% true-negative ratio at a leave-one-out test. After training, FIX automatically classified the ICA output of all the participants into 'good' and 'bad' components. 53.2 ± 14.9% of components were classified as 'bad' components and removed for all participants (49.5 ± 11.8% of the total variance). And then, the bad components and motion confounds with 24 motion parameters were regressed out from the preprocessed rs-fMRI data. After noise cleaning, the level of motion-related noise in term of the mean absolute displacement was significantly reduced in rs-fMRI data (p values \< 0.001 for both PD patients and healthy controls). However, the mean absolute displacement of PD patients still significantly differed from that of healthy controls (*p* \< 0.01). No difference was revealed between depressed and non-depressed patients (*p* \> 0.1).

2.3. The creation of patient-specific ICN template {#sec0005}
--------------------------------------------------

A patient-specific template of intrinsic connectivity network (ICN) was created by group-ICA from temporally concatenating data of all the patients. The group-ICA was performed using the MELODIC tool, with the number of components set to 100. By visual inspection, an independent component was categorized as an artifact when it had the following characteristics: 1) low spatial overlap with gray matter or high spatial overlap with the sagittal sinus, white matter, cerebrospinal fluid or brain\'s boundary in structural templates, 2) a large number of small clusters, 3) large high-frequency (\> 0.1 Hz) power in the time-course spectrum, and 4) the time series was bimodal or had sharp peaks or large jumps ([@bib0033]; [@bib0029]). Moreover, the component was not categorized as signal if it was driven by a single outlier subject ([@bib0025]). With the template, the approach of dual regression ([@bib0010]) was used to identify individual time courses and the associated spatial maps of all the ICNs for all participants.

2.4. The extraction of depression-related FC features {#sec0006}
-----------------------------------------------------

After dual regression, FC features including within-ICN and between-ICN connectivity strength were extracted for each participant. The within-ICN connectivity strength was computed to be the average value of the spatial map with z-score for each ICN. The between-ICN connectivity strength was estimated from the covariance matrix with the individual time courses of all the ICNs. The covariance was calculated from the regularized precision matrix using the graphical LASSO method ([@bib0011]), placing a penalty on the L1 norm of the precision matrix to promote sparsity with the regularization parameter λ set to 0.1. After Fisher transformation, a between-network connectivity matrix was obtained for each participant.

To identify features with significant discriminative power for depression diagnosis, FC features were put into an all-relevant feature selection procedure within cross-validation loops using the random forest algorithm (Supplementary Fig. 1), as described in a previous study ([@bib0036]). All PD patients were divided into two groups: patients with and without depression. The selection procedure was embedded in a repeated 10-fold cross-validation framework (repeated 100 times) to obtain unbiased estimates of classification error. For each iteration, a random forest classifier was constructed on the training set using the randomForest package ([@bib0039]) in Matlab (MathWorks, Natick, Massachusetts, USA). The performance of the classifier was evaluated on the validation set. Among all iterations, different subsets of features were selected on the basis of different folds. The selection frequency of each feature was defined as the number of iterations in which the feature was selected divided by the total number of iterations. Features with significantly higher selection frequency than random values defined by permutation test (permuted 1000 times; [@bib0036]) were identified as depression-related selections, with p value \< 0.05 after false discovery rate (FDR) correction for multiple comparisons ([@bib0006]).

3. Results {#sec0007}
==========

3.1. Demographic characteristics and clinical assessment {#sec0008}
--------------------------------------------------------

The demographic characteristics and clinical assessment of all participants were listed in [Table 1](#tbl0001){ref-type="table"}. There were no significant differences in age, sex, PDQI or MMSE among depressed patients, non-depressed patients and healthy controls (one-way ANOVA tests, p values \> 0.05). Depressed and non-depressed patients showed significant differences only in PD duration, HDRS and BDI scores (two-tailed t tests, p values \< 0.05), which implied that we could identify functional connectivity markers for depression and ignore some other factors including motor symptoms (UPDRS-III), sleep disorders (PSQI) and cognition impairment (MoCA and MMSE).Table 1The demographic and clinical information of all participants.Table 1D-PD (*n* = 59)ND-PD (*n* = 97)HC (*n* = 45)P valueAge (years)57.6 ± 10.7 (41 - 75)61.2 ± 9.5 (44 - 79)59.4 ± 10.0 (45 - 75)0.092[\*](#tb1fn1){ref-type="table-fn"}^,^[a](#tb1fn4){ref-type="table-fn"}Sex (M/FM)28/3151/4624/210.77[†](#tb1fn2){ref-type="table-fn"}PD duration (years)9.5 ± 2.9 (5 - 14)7.8 ± 2.4 (5 - 12)NA0.001[‡](#tb1fn3){ref-type="table-fn"}LEDD1056.4 ± 483.6 (250 - 1750)1004.8 ± 452.9 (250 - 1750)NA0.43[‡](#tb1fn3){ref-type="table-fn"}UPDRS III46.4 ± 15.2 (30 - 81)44.6 ± 13.5 (23.5 - 76)NA0.48[‡](#tb1fn3){ref-type="table-fn"}HDRS24.1 ± 10.5 (12 - 54)13.9 ± 6.7 (2 - 24)6.7 ± 4.6 (0 - 15)\< 0.001[\*](#tb1fn1){ref-type="table-fn"}^,^[b](#tb1fn5){ref-type="table-fn"}BDI21.5 ± 11.1 (9 - 48)8.1 ± 6.2 (2 - 20)4.9 ± 3.5 (0 - 12)\< 0.001[\*](#tb1fn1){ref-type="table-fn"}^,^[b](#tb1fn5){ref-type="table-fn"}PSQI15.7 ± 8.4 (4 - 34)14.2 ± 7.6 (2 - 32)12.7 ± 6.7 (1 - 26)0.14[\*](#tb1fn1){ref-type="table-fn"}^,^[a](#tb1fn4){ref-type="table-fn"}MoCA23.1 ± 5.4 (14 - 30)24.2 ± 4.6 (15 - 30)26.9 ± 2.4 (26 - 30)\< 0.001[\*](#tb1fn1){ref-type="table-fn"}^,^[c](#tb1fn6){ref-type="table-fn"}MMSE26.9 ± 3.1 (20 - 30)27.6 ± 2.8 (22 - 30)28.2 ± 2.1 (26 - 30)0.065[\*](#tb1fn1){ref-type="table-fn"}^,^[a](#tb1fn4){ref-type="table-fn"}[^2][^3][^4][^5][^6][^7][^8][^9]

3.2. Patient-specific ICN template and FC features {#sec0009}
--------------------------------------------------

42 ICNs in the patient-specific template were identified and arranged into subcortical (SC; 3 ICNs), auditory (AUD; 2 ICNs), somatomotor (SM; 6 ICNs), visual (VIS; 8 ICNs), cognitive control (CC; 11 ICNs), default-mode (DM; 9 ICNs) and cerebellar (CB; 3 ICNs) networks, on the basis of their anatomical and presumed functional properties ([Fig. 1](#fig0001){ref-type="fig"}A). FC features consisted of within-ICN and between-ICN connectivity strength. [Fig. 1](#fig0001){ref-type="fig"}B displays the distribution of within-ICN connectivity strength among patients and [Fig. 1](#fig0001){ref-type="fig"}C shows the FC strength between each two ICNs, averaged over patients and inverse Fisher transformed. The arrangement of ICNs was manually reordered based on network categories to optimize modularity and diagonal structure in [Fig. 1](#fig0001){ref-type="fig"}C, using the Brain Connectivity Toolbox (<http://www.brain-connectivity-toolbox.net/>).Fig. 1Spatial maps of the 42 ICNs in the patient-specific template and FC features including within-ICN and between-ICN connectivity strength. (A) 42 ICNs being arranged into subcortical (SC), auditory (AUD), somatomotor (SM), visual (VIS), cognitive control (CC), default-mode (DM) and cerebellar (CB) networks. Each color in a sub-network represents a different ICN. (B) The distribution of within-ICN connectivity strength (z-score) among patients. Each colored line corresponds to a different patient. (C) The FC strength between each two ICNs, averaged over patients and inverse Fisher transformed for display.Fig 1

3.3. The performance of random forest classifiers {#sec0010}
-------------------------------------------------

In constructing and evaluating the classifiers to discriminate depressed patients from the non-depressed, we repeated 100 times of 10-fold cross validation, which resulted in a total of 1000 training-testing cycles. The accuracy and Cohen\'s kappa coefficient of the random forest classifiers were 82.4 ± 5.1% and 0.61 ± 0.17, with features from the all-relevant feature selection procedure. The corresponding sensitivity and specificity were 78.5 ± 6.3% and 86.1 ± 7.2%, respectively.

3.4. Significantly relevant FC features {#sec0011}
---------------------------------------

After the feature selection was embedded into the 10-fold cross-validation procedure, a total of 1000 feature subsets were created for each random forest classifier. In the construction of the classifier discriminating between PD patients with and without depression, the mean number of features in each subset was 9.8 (range from 5 to 14; 0.55%−1.55% of all features). Six features ([Fig. 2](#fig0002){ref-type="fig"}) were identified to be significantly relevant to classification by the permutation test ([Table 2](#tbl0002){ref-type="table"}). These six features were FC within PCC, within insula, between insula and PCC, between insula and precuneus, between PCC and hippocampus+amygdala, and between superior parietal lobule (SPL) and medial prefrontal cortex (mPFC). Moreover, They showed significant differences between depressed and non-depressed patients (all p values \< 0.01, after FDR correction; [Fig. 2](#fig0002){ref-type="fig"} and [Table 2](#tbl0002){ref-type="table"}). And significant correlations were revealed between these features and depression scores (HDRS and BDI) in all patients (all p values \< 0.001, after FDR correction; [Fig. 3](#fig0003){ref-type="fig"}).Fig. 2Six identified FC features using the all-relevant feature selection algorithm. These features were FC within insula (A), within PCC (B), between insula and precuneus (C), between PCC and hippocampus+amygdala (D), between insula and PCC (E), and between SPL and mPFC (F). They showed significant differences between depressed and non-depressed patients. Compared to the healthy controls, these six features were significantly different in depressed patients and three of them (FC within PCC, between PCC and hippocampus+amygdala, and between SPL and mPFC) were significantly different in non-depressed patients, after regarding the mean absolute displacement and MoCA score as covariates. Statistical significance is indicated by asterisks (\*\*\*, *p* \< 0.001; \*\*, *p* \< 0.01). D-PD: depressed PD, HC: healthy controls, ND-PD: non-depressed PD.Fig 2Table 2Significantly relevant FC features to discriminate depressed and non-depressed PD patients.Table 2Selection Frequency (%)[\*](#tb2fn1){ref-type="table-fn"}Feature DescriptionD-PDND-PDHC91.1FC within PCC (ICN14)2.63 ± 0.032.31 ± 0.022.22 ± 0.0290.3FC between insula (ICN17) and PCC (ICN14)−0.25 ± 0.16−0.56 ± 0.31−0.46 ± 0.2888.4FC between insula (ICN17) and precuneus (ICN35)−0.27 ± 0.23−0.47 ± 0.33−0.42 ± 0.3186.1FC within insula (ICN17)2.25 ± 0.022.56 ± 0.022.64 ± 0.0382.1FC between PCC (ICN14) and hippocampus+amygdala (ICN47)−0.39 ± 0.23−0.24 ± 0.22−0.11 ± 0.1080.7FC between SPL (ICN15) and mPFC (ICN27)0.34 ± 0.210.22 ± 0.160.11 ± 0.09[^10][^11][^12]Fig. 3Correlations between depression-related features and depression scores in all patients. Significant correlations were revealed between six identified FC features and depression scores (HDRS, in green, and BDI, in blue; all *p* values \< 0.001, after FDR correction). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)Fig 3

Compared to the healthy controls, these six features were significantly different in depressed patients and three of them (FC within PCC, between PCC and hippocampus+amygdala, and between SPL and mPFC) were significantly different in non-depressed patients (ANCOVA tests, p values \< 0.05; [Fig. 2](#fig0002){ref-type="fig"}), after regarding the mean absolute displacement and MoCA score as covariates to consider the difference in the level of head motion during MRI scanning.

4. Discussion {#sec0012}
=============

In brief, our study indicated that resting-state functional connectivity, based on the patient-specific template, could characterize depression in PD and help diagnose whether advanced PD patients had depression or not. Six functional connectivity markers of depression were identified and listed as follows: FC within PCC, within insula, between insula and PCC, between insula and precuneus, between PCC and hippocampus+amygdala, and between SPL and mPFC. The mean accuracy of random forest classifiers to discriminate depressed patients from the non-depressed was 82.4%.

In this study, we focused on depression in advanced PD patients (duration \> 5 years). Previous studies showed that the duration of PD was a risk factor for incident depression in PD patients ([@bib0026]; [@bib0003]). In our cohort, the PD duration of depressed patients was significantly longer than that of non-depressed ones. And the incidence of depression in a total of 156 patients was 37.8%, relatively higher than that in early PD patients reported in some studies ([@bib0026]; [@bib0001]), which was helpful to the direct comparison of functional connectivity patterns between depressed and non-depressed patients. On account of the high incidence of depression in advanced PD and its great effect on patients' quality of life, the neural basis of depression in PD had been investigated through resting-state functional connectivity analysis in some fMRI studies ([@bib0030]; [@bib0020]; [@bib0019]; [@bib0013]). In our study, we extracted FC features including the whole-brain with-ICN and between-ICN connectivity strength on the basis of the patient-specific ICN template from a large number of PD patients. The specific template created by group-ICA and the direct comparison between depressed and non-depressed patients were to identity FC markers only for depression rather than PD. Next, FC features were put into an all-relevant feature selection procedure. In comparison with the commonly used feature selection methods such as *t*-test or Pearson\'s correlation analysis, the all-relevant feature selection algorithm could identify all features that significantly contributed to group discrimination. Moreover, there were no significant differences in patients' age, sex, dopaminergic medications (levodopa equivalent daily dose, LEDD), motor symptoms (UPDRS III), cognitive level (MoCA and MMSE) or sleep situation (PSQI) between depressed and non-depressed groups. Thus, it was valid to identify functional connectivity markers of depression in advanced PD patients through the mentioned analyses.

On the basis of identified features, our random forest classifiers achieved the mean accuracy of 82.4% to discriminate between patients with and without depression. Depression is a major factor in health-related quality of life in PD patients ([@bib0037]). [@bib0022] even revealed that the most important predictor for poor quality of life is not the severity of the motor symptoms or the duration of the illness but the presence of depression. However, depression in PD is under-diagnosed and under-treated due to overlapping symptoms and difficulties in the assessment of depression in old patients ([@bib0031]; [@bib0015]). Depression diagnosis in PD is not straightforward when several clinical presentations of depression and PD overlap ([@bib0021]). Physicians tend to concentrate on physical complaints and thus ignore emotional states in old PD patients, and many old patients are unwilling to share their feelings or deny being depressed ([@bib0023]). Moreover, many of depression-related symptoms, such as feelings of worthlessness, social withdrawal and isolation, may be dismissed by the clinicians as the natural consequence of physical mobility reduction and speech impairment in PD ([@bib0022]). In this situation, the classifier in our study was derived from patients' rs-fMRI data without performing any specific task, which revealed its potential clinical value for depression diagnosis in PD patients.

In our study, six FC features were identified to be relevant to group classification. All of these features not only showed group differences between depressed and non-depressed patients, but also significantly correlated with depression scores. Among all the involved ICNs, the PCC, mPFC and precuneus are the key nodes of the DMN, which has been proved to be associated with depression in previous studies ([@bib0038]; [@bib0005]). The DMN is activated during the resting state while deactivated during certain goal-oriented tasks in normal persons ([@bib0032]), whereas it failed to deactivate in depressed patients ([@bib0005]). Specifically, the PCC was involved in internally directed cognition including self-referential processing and rumination. Depressed patients tend to process negative information with regard to the self (self-referential processing) and fall into a persistent, repetitive and self-critical state (rumination), which can explain our findings about the increased FC within the PCC. Furthermore, we found that depressed patients had abnormal FC between the PCC and insula/hippocampus+amygdala, compared to non-depressed patients. And [@bib0007] showed reduced FC between the PCC and bilateral caudate for the comparison between depressed patients and healthy controls. These findings suggested that the FC within the PCC should be a contributing factor for depression, which was in accord with its important role in the group classification.

The insula, a cortical region beneath the frontal, temporal and parietal lobes, is an important part of the limbic system and has a well-established role in processing affect and emotion. [@bib0034] found that the gray matter volume in the insula was correlated with the severity of depression measured by the scores of clinical scales in patients with depression. In a rs-fMRI study, decreased regional homogeneity was revealed in the right insula in participants with depression ([@bib0018]), which was consistent with our results about the decreased FC within the insula and the neural correlate of depression in PD. Moreover, we found that depressed patients had abnormal FC between insula and PCC/precuneus, and between hippocampus+amygdala and PCC. These results indicated that the interaction between the limbic system and DMN was closely associated with depression in PD patients.

We acknowledge a few limitations to our study. First, we did not recruit patients only with depression in this study. We identified six FC markers relevant to depression diagnosis in PD, but we did not know whether these markers also acted for the discrimination between general depressed patients and healthy controls. Second, the mean HDRS and BDI scores of non-depressed patients were 13.9 and 8.1 respectively, which meant some of them might have mild depression. All patients were diagnosed to have depression or not according to the DSM-IV criteria by an experienced psychiatrist. HDRS and BDI could be less accurate than DSM as the diagnostic criteria for depression in PD, due to overlapping mental symptoms such as apathy and anxiety. If we excluded non-depressed patients with a BDI score \> 14 or HDRS score \> 20 (18 patients in total) and performed the feature selection procedure again, the subset of depression-related features did not change while the mean accuracy of the classifiers was 86.7%, a bit higher than the original one. However, one of our aims in the study was to help clinical diagnosis of depression in PD and we tried to make the classifiers target as general PD patients as possible. Thus we preferred to include these non-depressed patients.

In conclusion, compared to advanced PD patients without depression and healthy control subjects, we found abnormal functional connectivity within and between the limbic system and default mode network in patients with depression, which significantly contributed to group classification. On the basis of identified FC markers of depression, moderately successful discrimination was achieved for clinical diagnosis of depression in advanced PD patients.
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[^2]: BDI = Beck Depression Inventory, D-PD = depressed PD, FM = female, HC = healthy controls, HDRS = Hamilton Depression Rating Scale, LEDD = levodopa equivalent daily dose, *M* = male, MMSE = Mini-Mental State Examination, MoCA = Montreal Cognitive Assessment Scale, NA = not applicable, ND-PD = non-depressed PD, PSQI = Pittsburgh Sleep Quality Index, UPDRS III = Unified Parkinson\'s Disease Rating Scale part III.

[^3]: Values are represented as the mean ± standard deviation with the range in parentheses, except for the gender distribution. For comparisons of demographic and clinical characteristics:.

[^4]: P values were calculated with One-way ANOVA tests.

[^5]: P value was obtained using a chi-squared test.

[^6]: P values were calculated with two-tailed t tests.

[^7]: Post-hoc paired comparisons showed no significant differences between each two of the three groups.

[^8]: Post-hoc paired comparisons showed significant differences between each two of the three groups.

[^9]: Post-hoc paired comparisons showed significant differences between D-PD and HC, and between ND-PD and HC. *P* \< 0.05 was considered significant.

[^10]: D-PD = depressed PD, FC = functional connectivity, HC = healthy controls, mPFC = medial prefrontal cortex, ND-PD = non-depressed PD, PCC = posterior cingulate cortex, SPL = superior parietal lobule.

[^11]: Values are represented as the mean ± standard deviation, except for the selection frequency.

[^12]: Defined as the number of iterations in which the feature was selected divided by the total number of iterations performed.
